William Blair & Company’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-440
| Closed | -$14K | – | 1939 |
|
|
2021
Q2 | $14K | Sell |
440
-150
| -25% | -$4.77K | ﹤0.01% | 1799 |
|
|
2021
Q1 | $15K | Buy |
590
+115
| +24% | +$2.92K | ﹤0.01% | 1769 |
|
|
2020
Q4 | $12K | Buy |
475
+50
| +12% | +$1.26K | ﹤0.01% | 1735 |
|
|
2020
Q3 | $9K | Buy |
425
+135
| +47% | +$2.86K | ﹤0.01% | 1637 |
|
|
2020
Q2 | $7K | Sell |
290
-235
| -45% | -$5.67K | ﹤0.01% | 1612 |
|
|
2020
Q1 | $9K | Sell |
525
-1,150
| -69% | -$19.7K | ﹤0.01% | 1567 |
|
|
2019
Q4 | $40K | Buy |
+1,675
| New | +$40K | ﹤0.01% | 1512 |
|
|
2018
Q1 | – | Sell |
-11,171
| Closed | -$445K | – | 1566 |
|
|
2017
Q4 | $445K | Buy |
11,171
+4,161
| +59% | +$166K | ﹤0.01% | 1000 |
|
|
2017
Q3 | $280K | Buy |
+7,010
| New | +$280K | ﹤0.01% | 1136 |
|